Accrued Expenses

3 Months Ended

Mar. 31, 2024

Accrued Expenses [Abstract]

Accrued Expenses

(5) Accrued Expenses

Accrued expenses consisted of the following:

	March 31,		December 31,
	2024		2023
Clinical trial costs	$	243,367		276,141
Accrued interest		147,275		—
Incentive and other compensation costs		146,409		1,082,606
Director fees		70,000		60,210
Franchise taxes		12,800		12,160
Other		53,606		13,179
Accrued expenses	$	673,457		1,444,296